Abstract
To identify known and novel CYP4V2 mutations in patients with Bietti crystalline cornea (BCD), expand the spectrum of CYP4V2 mutations, and characterize the population history of the c.802-8_810del17insGC mutation common in Asian populations, genomic DNA was isolated from peripheral blood samples from 58 unrelated patients with clinical diagnoses of BCD. Exons and flanking intronic regions of the CYP4V2 gene were dideoxy DNA sequenced. Nonpathogenic polymorphisms were excluded and known mutations were identified by sequencing 192 unaffected individuals from similar ethnic backgrounds and examination of online databases. The age of the c.802-8_810del17insGC mutation was estimated using three independent approaches. A total of 28 CYP4V2 mutations, 9 of which were novel, were detected in the 58 patients with BCD. These included 19 missense, 4 nonsense, 2 deletion, 2 splice site, and 1 insertion-deletion mutations. Two missense variants of uncertain significance were also detected. The age of the c.802-8_810del17insGC mutation was estimated to be 1040–8200 generations in the Chinese and 300–1100 generations in the Japanese populations. These results expand the mutation spectrum of CYP4V2, and provide insight into the origin of the c.802-8_810del17insGC mutation in the Chinese population and its transmission to the Japanese population.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kaiser-Kupfer MI, Chan CC, Markello TC et al: Clinical biochemical and pathologic correlations in Bietti’s crystalline dystrophy. Am J Ophthalmol 1994; 118: 569–582.
Hu DN : Prevalence and mode of inheritance of major genetic eye diseases in China. J Med Genet 1987; 24: 584–588.
Lee J, Jiao X, Hejtmancik JF, Kaiser-Kupfer M, Chader GJ : Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD). Mol Genet Metab 1998; 65: 143–154.
Lee J, Jiao X, Hejtmancik JF et al: The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci 2001; 42: 1707–1714.
Li A, Jiao X, Munier FL et al: Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 2004; 74: 817–826.
Nakano M, Kelly EJ, Rettie AE : Expression and characterization of CYP4V2 as a fatty acid {omega}-hydroxylase. Drug Metab Dispos 2009; 37: 2119–2122.
Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE : CYP4V2 in Bietti’s crystalline dystrophy: ocular localization, metabolism of omega-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol 2012; 82: 679–686.
Lai T, Chu KO, Chan KP et al: Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci 2010; 51: 1092–1097.
Lockhart CM, Nakano M, Rettie AE, Kelly EJ : Generation and characterization of a murine model of Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci 2014; 55: 5572–5581.
Smith RJH, Holcomb JD, Daiger SP et al: Exclusion of Usher syndrome gene from much of chromosome 4. Cytogenet Cell Genet 1989; 50: 102–106.
Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T : Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 2009; 4: 1–13.
Arnold K, Bordoli L, Kopp J, Schwede T : The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195–201.
Biasini M, Bienert S, Waterhouse A et al: SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 2014; 42: W252–W258.
Sayle RA, Milner-White EJ : RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995; 20: 374.
Risch N, de Leon D, Ozelius L et al: Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995; 9: 152–159.
Colombo R : Age and origin of the PRNP E200K mutation causing familial Creutzfeldt–Jacob disease in Libyan Jews. Am J Hum Genet 2000; 67: 528–531.
Goldstein DB, Reich DE, Bradman N, Usher S, Seligsohn U, Peretz H : Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet 1999; 64: 1071–1075.
Slatkin M, Rannala B : Estimating allele age. Annu Rev Genomics Hum Genet 2000; 1: 225–249.
Reeve JP, Rannala B : DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002; 18: 894–895.
Henikoff S, Henikoff JG : Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992; 89: 10915–10919.
Grantham R : Amino acid difference formula to help explain protein evolution. Science 1974; 185: 862–864.
Lin J, Nishiguchi KM, Nakamura M, Dryja TP, Berson EL, Miyake Y : Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. J Med Genet 2005; 42: e38.
Lee KY, Koh AH, Aung T et al: Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci 2005; 46: 3812–3816.
Shan M, Dong B, Zhao X et al: Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy. Mol Vis 2005; 11: 738–743.
Bezemer ID, Bare LA, Doggen CJ et al: Gene variants associated with deep vein thrombosis. JAMA 2008; 299: 1306–1314.
Meng XH, Guo H, Xu HW et al: Identification of novel CYP4V2 gene mutations in 92 Chinese families with Bietti’s crystalline corneoretinal dystrophy. Mol Vis 2014; 20: 1806–1814.
Yin H, Jin C, Fang X et al: Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy. PLoS One 2014; 9: e94960.
Lai TY, Ng TK, Tam PO et al: Genotype phenotype analysis of Bietti’s crystalline dystrophy in patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci 2007; 48: 5212–5220.
Tian R, Wang SR, Wang J, Chen YX : Novel CYP4V2 mutations associated with Bietti crystalline corneoretinal dystrophy in Chinese patients. Int J Ophthalmol 2015; 8: 465–469.
Xiao X, Mai G, Li S, Guo X, Zhang Q : Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. Biochem Biophys Res Commun 2011; 409: 181–186.
Hayakawa M, Fujiki K, Kanai A et al: Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol 1997; 41: 1–6.
Wada Y, Itabashi T, Sato H, Kawamura M, Tada A, Tamai M : Screening for mutations in CYP4V2 gene in Japanese patients with Bietti’s crystalline corneoretinal dystrophy. Am J Ophthalmol 2005; 139: 894–899.
Yokoi Y, Sato K, Aoyagi H, Takahashi Y, Yamagami M, Nakazawa M : A novel compound heterozygous mutation in the CYP4V2 gene in a Japanese patient with Bietti’s crystalline corneoretinal dystrophy. Case Rep Ophthalmol 2011; 2: 296–301.
Jin ZB, Ito S, Saito Y, Inoue Y, Yanagi Y, Nao-i N : Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn J Ophthalmol 2006; 50: 426–431.
Hu DN : Ophthalmic genetics in China. Ophthalmic Paediatr Genet 1983; 2: 39–45.
Rannala B, Reeve JP : High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence. Am J Hum Genet 2001; 69: 159–178.
Rossi S, Testa F, Li A et al: Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br J Ophthalmol 2013; 97: 174–179.
Halford S, Liew G, Mackay DS et al: Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy. Ophthalmology 2014; 121: 1174–1184.
Wang F, Wang H, Tuan HF et al: Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet 2014; 133: 331–345.
Haddad NM, Waked N, Bejjani R et al: Clinical and molecular findings in three Lebanese families with Bietti crystalline dystrophy: report on a novel mutation. Mol Vis 2012; 18: 1182–1188.
Acknowledgements
We would like to thank the families and patients who participated in this work. In addition, we are grateful to NEI project EYE000272 for support. MBG has received support from the Department of Ophthalmology at UCLA, the Harold and Pauline Price Foundation, and from Research to Prevent Blindness, New York, NY. ZBJ has received support from the National Natural Science Foundation of China (81522014, 81371059). AI is supported by the Research to Prevent Blindness, New York, NY (Physician Scientist Award to AI and unrestricted grant to the UTHSC Department of Ophthalmology).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Jiao, X., Li, A., Jin, ZB. et al. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy. Eur J Hum Genet 25, 461–471 (2017). https://doi.org/10.1038/ejhg.2016.184
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2016.184
This article is cited by
-
Clinical and genetic characterization of a large cohort of Chinese patients with Bietti crystalline retinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology (2024)
-
Targeted lipidomics uncovers oxylipin perturbations and potential circulation biomarkers in Bietti’s crystalline dystrophy
Graefe's Archive for Clinical and Experimental Ophthalmology (2024)
-
Observation of the characteristics of the natural course of Bietti crystalline dystrophy by fundus fluorescein angiography
BMC Ophthalmology (2021)
-
Multimodal imaging features and genetic findings in Bietti crystalline dystrophy
BMC Ophthalmology (2020)
-
Association of the CYP4V2 polymorphism rs13146272 with venous thromboembolism in a Chinese population
Clinical and Experimental Medicine (2019)
